New GYN Oncologist Joins First ...

Dr. Beverly Long, MD

Claim this profile

Sarasota Memorial Hospital

Studies Ovarian Cancer
Studies Uterine Cancer
15 reported clinical trials
29 drugs studied

Area of expertise

1

Ovarian Cancer

Beverly Long, MD has run 8 trials for Ovarian Cancer. Some of their research focus areas include:

BRCA1 positive
FRα positive
MMR negative
2

Uterine Cancer

Beverly Long, MD has run 5 trials for Uterine Cancer. Some of their research focus areas include:

Stage III
Stage I
Stage IV

Affiliated Hospitals

Image of trial facility.

Sarasota Memorial Hospital

Image of trial facility.

Florida Cancer Specialists - Venice Healthpark

Clinical Trials Beverly Long, MD is currently running

Image of trial facility.

Olvi-Vec + Chemotherapy

for Ovarian Cancer

The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objective response rate and progression-free survival observed in heavily pre-treated patients with platinum-resistant/refractory ovarian cancer. The phase II results also showed that the intra-peritoneal route of delivery was efficient in generating tumor cell killing and immune activation, and led to clinical reversal of platinum-resistance or refractoriness in this difficult-to-treat patient population.

Recruiting

2 awards

Phase 3

7 criteria

Image of trial facility.

Tailored Therapy

for Endometrial Cancer

This phase II trial tests how well tailoring therapy in post-surgery works in patients with low-risk endometrial cancer. The usual approach for patients with low-risk endometrial cancer is treatment with surgery. In this study, tissue that is removed as part of the surgical procedure is analyzed in the pathology laboratory to help guide the doctor to decide whether or not additional treatment such as radiation and or chemotherapy should be recommended.

Recruiting

1 award

Phase 2

4 criteria

More about Beverly Long, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 6 Active Clinical Trials

Treatments Beverly Long, MD has experience with

  • Carboplatin
  • Bevacizumab
  • Paclitaxel
  • ZN-c3
  • Quality-of-Life Assessment
  • Biospecimen Collection

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Beverly Long, MD specialize in?

Is Beverly Long, MD currently recruiting for clinical trials?

Are there any treatments that Beverly Long, MD has studied deeply?

What is the best way to schedule an appointment with Beverly Long, MD?

What is the office address of Beverly Long, MD?

Is there any support for travel costs?